Chelation therapy is an intravenous therapy using the synthetic amino acid “EDTA” (ethylenediaminetetraacetic acid) to bind with metal ions forming a stable heterocyclic ring structure. This, in turn, transports the toxic metals to the kidneys whereupon they are excreted. EDTA has the ability to bond with atoms of calcium, lead, cadmium, mercury, and others as well as some of the trace minerals through the process of chelation.

For more than 50 years, chelation therapy has been used successfully for patients with vascular diseases such as atherosclerosis as well as heavy metal poisoning. The FDA has approved (ca) chelation as the only treatment for lead poisoning.

Improving circulation by the removal of accumulated build-up (plaques) that damage the vascular system throughout the body is a primary benefit for patients with CVD (cardiovascular disease), atherosclerosis, diabetes or other circulatory diseases. During and following chelation therapy, plaques are resolved with the improvement of the removal of the heavy metals and biochemical interactions of nutrients.

In addition to EDTA, patients receive vitamins and minerals in their IV solutions that are essential to optimal health. The physician will review the basic program of non-smoking, diet, exercise, and vitamin and mineral supplementation, the patient is expected to follow throughout the treatment and as a lifestyle change.
History

Ethylenediaminetetraacetic acid (EDTA) was developed in Europe in the first half of the last century (1900) for use in industry and water purification (removal of lead, etc.). It was found to have a particular affinity to chelation properties, especially in regards to the heavy metals, and became an inexpensive way to purify drinking water.

 

A Brief History

In the 1940s, already in use by German armed forces. The US naval physicians began noticing a high incidence of lead poisoning among sailors assigned the duty of painting warships. The physicians used intravenous (IV) EDTA chelation therapy to remove the lead with excellent results. In the 1950s, physicians treating heavy metal toxicity also noticed that their patients with angina pectoris no longer complained of chest pain after a few EDTA treatments, and EDTA chelation therapy became popular into the 1960s as a treatment for coronary and other vascular diseases. However, with the advent of evidence-based medicine, EDTA therapy lost favor and has been regarded as “alternative medicine” until just recently. However, due to 40 years of positive data, the National Institutes of Health (NIH) started a double-blind study of patients with coronary artery disease beginning in March 2003. (See TACT Trial). Estimates about the numbers of physicians practicing chelation therapy are difficult to obtain because many physicians have been reluctant to make themselves objects of scrutiny.

 

How Many Treatments Are Warranted?

The recommended initial series for most patients is 30 treatments. Some patients choose more than 30 treatments to achieve maximum improvement in their blood flow. These treatments can be done 1, 2, or 3 times a week, but no more. Maintenance treatments are recommended at one or two-month intervals to maintain improved circulation. There are virtually no dangerous side effects from this treatment, although some experience a brief period of fatigue after treatment.

 

What Are the Results of Chelation Therapy?

The results are as varied as patients’ conditions, but improvement is usually achieved. Chest pain may be lessened, blood pressure lowered, memory improved, transient ischemic attacks stopped, leg pain relieved, cold extremities warmed up and increased work tolerance. Hearing improvement can be accomplished if not due to injury. The laboratory tests and office visits for evaluation will monitor progress.

 

Innovation Compounding's IV Protocol Kits

Since day one, prescribers have trusted Innovation Compounding for its ability to assist in initiating the best plan of therapy suitable for their patients. Our pharmacy is a trusted source of high quality, sterile infusions that are compounded for individual patient needs. All compounded products are formulated in facilities compliant with all relevant regulatory and quality accreditations.

Connect with a member of our sterile compounding team to discuss our protocols for chelation therapy.

 

Connect with Us

If you have any questions or would like additional information, please contact Innovation Compounding at 1-800-547-1399, Monday-Friday, 9 a.m. to 5 p.m. EST, excluding all major holidays.

Pharmacy Hours (EST)
Sunday Closed
Monday 9AM - 6PM
Tuesday 9AM - 6PM
Wednesday 9AM - 6PM
Thursday 9AM - 6PM
Friday 9AM - 5PM
Saturday Closed

Our staff is full of compassionate health care professionals ready to counsel practitioners and patients alike. We’re here to listen to you, research your needs, and provide you with not only medication, but also the knowledge to reach your desired health goals.

Information contained on this site is provided as an informational aide and for reference use only. The content herein is not intended to be, act as, or replace medical advice or diagnosis for individual health conditions nor is it making evaluations as to the risks or benefits of particular preparations. Please consult a licensed healthcare professional about diagnosis and treatment. Information and statements on this site have not been evaluated by the Food and Drug Administration.

CONNECT WITH US

6095 Pine Mountain Rd. NW,
Suite 108
Kennesaw, GA 30152

(800) 547-1399 Ph.
(866) 635-2329 Fax

Hours:
9:00 a.m.-6:00 p.m. M-Th
9:00 a.m.-5:00 p.m. Fri

   

An account is required to prescribe through our Prescriber Portal.

 

If you would like to access our Prescriber Portal

 

Please choose from one of the options below:

You have Successfully Subscribed!